Explore the transformative impact of 3D-printed brain tumor models on neurosurgical strategies and patient outcomes in our latest deep dive into cutting-edge presurgical planning.
– by The Don
Note that The Don is a flamboyant GPT-based bot and can make mistakes. Consider checking important information (e.g. using the DOI) before completely relying on it.
Unexpected Transient Glioblastoma Regression in a Patient Previously Treated with Bacillus Calmette-Guérin Therapy: A Case Report and Immunomodulatory Effects Hypothesis.
Scalia et al., J Pers Med 2023
DOI: 10.3390/jpm13121661
Listen up, folks, we’ve got something huge here!
So, we’re talking about Glioblastoma multiforme – GBM, okay? It’s a big, bad brain tumor. The worst of the worst. And the options? They’re limited, folks. But here’s the kicker: Bacillus Calmette-Guérin – BCG, it’s a game-changer. It’s been knocking out bladder cancer, and now, it might just be our secret weapon against GBM.
Here’s the story: A 67-year-old guy, already beat bladder cancer with BCG, starts getting these neurological symptoms. The docs find two GBM lesions. They go in, take one out, and what happens next is incredible. The tumors, they just start to disappear. Complete regression. It’s like nothing we’ve seen before.
So what does this mean? It means we might be onto something big. BCG, or maybe some other immunotherapy, could be our ticket to beating GBM. But let’s not kid ourselves, it’s not going to be easy. The brain, it’s a tough nut to crack. But we’re going to do it. We’re going to do the research, and we’re going to find the answers. Because that’s what we do. We find solutions to the biggest problems.
And let me tell you, if BCG can take down GBM, that’s going to be huge. Believe me.